These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
592 related articles for article (PubMed ID: 21715480)
21. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Cao R; Zhang Y Mol Cell; 2004 Jul; 15(1):57-67. PubMed ID: 15225548 [TBL] [Abstract][Full Text] [Related]
22. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282 [TBL] [Abstract][Full Text] [Related]
23. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Simon JA; Lange CA Mutat Res; 2008 Dec; 647(1-2):21-9. PubMed ID: 18723033 [TBL] [Abstract][Full Text] [Related]
24. Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. Imai K; Togami H; Okamoto T J Biol Chem; 2010 May; 285(22):16538-45. PubMed ID: 20335163 [TBL] [Abstract][Full Text] [Related]
25. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Fiskus W; Wang Y; Sreekumar A; Buckley KM; Shi H; Jillella A; Ustun C; Rao R; Fernandez P; Chen J; Balusu R; Koul S; Atadja P; Marquez VE; Bhalla KN Blood; 2009 Sep; 114(13):2733-43. PubMed ID: 19638619 [TBL] [Abstract][Full Text] [Related]
26. A model for transmission of the H3K27me3 epigenetic mark. Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660 [TBL] [Abstract][Full Text] [Related]
27. Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression. Liu Y; Niu Y; Li L; Timani KA; He VL; Sanburns C; Xie J; He JJ J Neurovirol; 2019 Aug; 25(4):508-519. PubMed ID: 31020497 [TBL] [Abstract][Full Text] [Related]
28. Role of hPHF1 in H3K27 methylation and Hox gene silencing. Cao R; Wang H; He J; Erdjument-Bromage H; Tempst P; Zhang Y Mol Cell Biol; 2008 Mar; 28(5):1862-72. PubMed ID: 18086877 [TBL] [Abstract][Full Text] [Related]
29. EZH2 methyltransferase and H3K27 methylation in breast cancer. Yoo KH; Hennighausen L Int J Biol Sci; 2012; 8(1):59-65. PubMed ID: 22211105 [TBL] [Abstract][Full Text] [Related]
30. Gene silencing in HIV-1 latency by polycomb repressive group. Kim HG; Kim KC; Roh TY; Park J; Jung KM; Lee JS; Choi SY; Kim SS; Choi BS Virol J; 2011 Apr; 8():179. PubMed ID: 21496352 [TBL] [Abstract][Full Text] [Related]
31. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Margueron R; Li G; Sarma K; Blais A; Zavadil J; Woodcock CL; Dynlacht BD; Reinberg D Mol Cell; 2008 Nov; 32(4):503-18. PubMed ID: 19026781 [TBL] [Abstract][Full Text] [Related]
32. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Cha TL; Zhou BP; Xia W; Wu Y; Yang CC; Chen CT; Ping B; Otte AP; Hung MC Science; 2005 Oct; 310(5746):306-10. PubMed ID: 16224021 [TBL] [Abstract][Full Text] [Related]
33. The polycomb group protein SUZ12 regulates histone H3 lysine 9 methylation and HP1 alpha distribution. de la Cruz CC; Kirmizis A; Simon MD; Isono K; Koseki H; Panning B Chromosome Res; 2007; 15(3):299-314. PubMed ID: 17406994 [TBL] [Abstract][Full Text] [Related]
34. Loss of BAP1 function leads to EZH2-dependent transformation. LaFave LM; Béguelin W; Koche R; Teater M; Spitzer B; Chramiec A; Papalexi E; Keller MD; Hricik T; Konstantinoff K; Micol JB; Durham B; Knutson SK; Campbell JE; Blum G; Shi X; Doud EH; Krivtsov AV; Chung YR; Khodos I; de Stanchina E; Ouerfelli O; Adusumilli PS; Thomas PM; Kelleher NL; Luo M; Keilhack H; Abdel-Wahab O; Melnick A; Armstrong SA; Levine RL Nat Med; 2015 Nov; 21(11):1344-9. PubMed ID: 26437366 [TBL] [Abstract][Full Text] [Related]
35. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699 [TBL] [Abstract][Full Text] [Related]
36. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138 [TBL] [Abstract][Full Text] [Related]
37. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. Mochizuki-Kashio M; Mishima Y; Miyagi S; Negishi M; Saraya A; Konuma T; Shinga J; Koseki H; Iwama A Blood; 2011 Dec; 118(25):6553-61. PubMed ID: 22042701 [TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Zeng X; Chen S; Huang H Cell Cycle; 2011 Feb; 10(4):579-83. PubMed ID: 21278485 [TBL] [Abstract][Full Text] [Related]